Related Experiment Video
Updated: Jul 14, 2026
10:59
Artificial RNA Polymerase II Elongation Complexes for Dissecting Co-transcriptional RNA Processing Events
Published on: May 13, 2019
Human RNA polymerase II-associated factor complex: dysregulation in cancer
K Chaudhary1, S Deb, N Moniaux
1Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198-5870, USA.
Oncogene
|June 30, 2007
Summary
Genetic instabilities drive cancer. The human RNA polymerase II-associated factor (hPAF) complex, particularly its PD2/hPaf1 subunit, is amplified and overexpressed in cancers, suggesting a role in tumorigenesis.
Area of Science:
- Molecular Biology
- Cancer Genetics
- Epigenetics
Background:
- Genetic instabilities and aberrant protein expression are key drivers of cancer development.
- The human RNA polymerase II-associated factor (hPAF) complex, homologous to yeast PAF, plays roles in transcription, mRNA quality control, and cell-cycle regulation.
Purpose of the Study:
- To review the functions of the PAF complex and its subunits.
- To explore the interactions between PAF subunits and other molecules.
- To investigate the dysregulation of the PAF complex in cancer development.
Main Methods:
- Differential screening analysis to identify gene amplifications.
- Literature review of studies on the PAF complex and its subunits.
- Analysis of protein expression and genetic modifications in cancer.
Main Results:
- Amplification of the 19q13 locus containing the pancreatic differentiation 2 (PD2) gene was identified.
- PD2/hPaf1, a core subunit of hPAF, is amplified and overexpressed in numerous cancers.
- Overexpression of PD2/hPaf1 induces a transformed cellular phenotype, implicating it in tumorigenesis.
Conclusions:
- The hPAF complex, particularly PD2/hPaf1, is implicated in cancer development due to its amplification and overexpression.
- Dysregulation of the hPAF complex and its subunits may contribute to the malignant phenotype.
- Further research into the hPAF complex's role in cancer is warranted.
More Related Videos
10:49A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TEdeff) in Cancers
Published on: September 26, 2019
11:11Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells
Published on: April 25, 2018
Related Concept Videos
02:36RNA Polymerase II Accessory Proteins
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
02:36RNA Polymerase II Accessory Proteins
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
00:58Eukaryotic RNA Polymerases
RNA Polymerase (RNAP) is conserved in all animals, with bacterial, archaeal, and eukaryotic RNAPs sharing significant sequence, structural, and functional similarities. Among the three eukaryotic RNAPs, RNA Polymerase II is most similar to bacterial RNAP in terms of both structural organization and folding topologies of the enzyme subunits. However, these similarities are not reflected in their mechanism of action.
All three eukaryotic RNAPs require specific transcription factors, of which the...
All three eukaryotic RNAPs require specific transcription factors, of which the...
00:58Eukaryotic RNA Polymerases
RNA Polymerase (RNAP) is conserved in all animals, with bacterial, archaeal, and eukaryotic RNAPs sharing significant sequence, structural, and functional similarities. Among the three eukaryotic RNAPs, RNA Polymerase II is most similar to bacterial RNAP in terms of both structural organization and folding topologies of the enzyme subunits. However, these similarities are not reflected in their mechanism of action.
All three eukaryotic RNAPs require specific transcription factors, of which the...
All three eukaryotic RNAPs require specific transcription factors, of which the...
01:47Transcription Initiation
Initiation is the first step of transcription in eukaryotes. Prokaryotic RNA Polymerase (RNAP) can bind to the template DNA and start transcribing. On the other hand, transcription in eukaryotes requires additional proteins, called transcription factors, to first bind to the promoter region in the DNA template. This binding helps recruit the specific RNAP that can assemble on the DNA and start transcription.
The promoters and enhancers and their accessory proteins allow tight regulation of...
The promoters and enhancers and their accessory proteins allow tight regulation of...
01:30General Transcription Factors
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...